Analyst firms · Robert W. Baird · TIL
Robert W. Baird TIL price target and rating history
Instil Bio Inc. (TIL) · Health Care
Robert W. Baird rates Instil Bio Inc. (TIL) Neutral with a $7 price target, as of its latest action on Jan 6, 2026. It has published 3 rating actions on TIL since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $7
- Median target, all firms
- Too few
- Actions on TIL
- 3
Robert W. Baird price target on TIL
Every Robert W. Baird rating on TIL
- Jan 6, 2026
- Aug 13, 2021
- Aug 13, 2021
How other firms rate TIL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Neutral | Jan 7, 2026 | |
| Robert W. Baird | Neutral | $7 | Jan 6, 2026 |
Questions about Robert W. Baird and TIL
- What is Robert W. Baird's price target for TIL?
- Robert W. Baird's latest stated price target for Instil Bio Inc. (TIL) is $7, from its action on Jan 6, 2026.
- What is Robert W. Baird's rating on TIL?
- Robert W. Baird rates TIL Neutral, a neutral rating, as of Jan 6, 2026.
- When did Robert W. Baird last change its view on TIL?
- On Jan 6, 2026, Robert W. Baird downgrades to Neutral from Outperform, price target $7.
All Robert W. Baird ratingsTIL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.